Balancing Hope with Uncertainty

With many new agents approved for the treatment of lung cancer, it is a tremendously exciting time for oncologists. But when treatments are so new and oncologists don’t yet fully understand their proper use or real risks and benefits for the patient sitting in front of them, determining the right thing to do is a challenge. Care pathways help, but cannot fully replace a physician’s judgment. And, of course, there is patient preference to consider in this new era of collaborative medical decision making.

In his most recent ASCO Connection blog post, Cleveland Clinic oncologist Nathan Pennell, MD, PhD, discusses the complexities of moving new drugs into practice and encourages colleagues from all sides to continue the conversation.

Read the full article.